Kintor Pharmaceutical Limited
HKEX:9939.HK
1.13 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0.034 | 0 | 0 | 0.001 | 0.49 | 1.458 | 0 | 0 |
| Cost of Revenue
| 42.229 | 0 | 0 | 0 | 0 | 0.001 | 0.35 | 0.37 | 0 | 0 |
| Gross Profit
| -42.229 | 0 | 0.034 | 0 | 0 | 0 | 0.14 | 1.088 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 1 | 0 | 0 | 0.013 | 0.285 | 0.746 | 0 | 0 |
| Reseach & Development Expenses
| 938.907 | 827.974 | 0.768 | 328.764 | 214.019 | 0.093 | 44.748 | 23.515 | 10.521 | 7.545 |
| General & Administrative Expenses
| 88.363 | 131.032 | 0.102 | 76.074 | 19.536 | 0.024 | 49.473 | 59.535 | 12.953 | 9.174 |
| Selling & Marketing Expenses
| 6.984 | 20.326 | 0.015 | 8.628 | 0.336 | 0 | 0.001 | 0 | 0.001 | 0.001 |
| SG&A
| 96.029 | 152.575 | 0.118 | 85.691 | 20.587 | 0.024 | 50.207 | 59.976 | 13.596 | 9.71 |
| Other Expenses
| 0 | 0 | 0.419 | 0 | 0 | 0.009 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 1,030.019 | 951.979 | 0.886 | 515.268 | 232.818 | 0.109 | 44.814 | 55.461 | 11.703 | 8.279 |
| Operating Income
| -1,069.675 | -969.124 | -0.835 | -399.743 | -218.219 | -0.11 | -46.087 | -58.909 | -13.596 | -9.71 |
| Operating Income Ratio
| 0 | 0 | -24.384 | 0 | 0 | -157.069 | -94.071 | -40.394 | 0 | 0 |
| Total Other Income Expenses Net
| 0.814 | 15.84 | -0.007 | -108.485 | -14.358 | 0.001 | -0.122 | 4.697 | 2.145 | 1.357 |
| Income Before Tax
| -1,068.861 | -953.284 | -0.842 | -508.228 | -232.577 | -0.108 | -46.209 | -54.212 | -11.452 | -8.353 |
| Income Before Tax Ratio
| 0 | 0 | -24.6 | 0 | 0 | -155.421 | -94.32 | -37.173 | 0 | 0 |
| Income Tax Expense
| 8.041 | 1.085 | -0.23 | 0.073 | 0 | -0.16 | 0.007 | 0.014 | 0.011 | 0.007 |
| Net Income
| -1,060.82 | -954.369 | -0.842 | -508.301 | -232.577 | -0.108 | -46.217 | -54.226 | -11.441 | -8.346 |
| Net Income Ratio
| 0 | 0 | -24.6 | 0 | 0 | -155.421 | -94.335 | -37.183 | 0 | 0 |
| EPS
| -2.47 | -2.53 | -2.36 | -1.64 | -0.97 | -0.5 | -0.24 | -0.29 | -0.068 | -0.057 |
| EPS Diluted
| -2.47 | -2.53 | -2.36 | -1.64 | -0.97 | -0.5 | -0.24 | -0.29 | -0.068 | -0.057 |
| EBITDA
| -1,055.821 | -956.446 | -0.828 | -396.326 | -216.39 | -0.108 | -44.996 | -58.413 | -13.298 | -9.497 |
| EBITDA Ratio
| 0 | 0 | -24.188 | 0 | 0 | -155.236 | -91.844 | -40.054 | 0 | 0 |